Medicine Central™ is a quick-consult mobile and web resource that includes diagnosis, treatment, medications, and follow-up information on over 700 diseases and disorders, providing fast answers—anytime, anywhere. Explore these free sample topics:
-- The first section of this topic is shown below --
- Chronic, widespread noninflammatory musculoskeletal pain syndrome with multisystem manifestations. Although the specific pathophysiology has not been elucidated, it is generally thought to be a disorder of altered central pain regulation.
- Synonym(s): FMS; fibrositis, fibromyositis (misnomers); “psychogenic rheumatism” (archaic and inaccurate)
- Predominant sex: female (70–90%) > male (1)
- Predominant age range: 20 to 65 years
2–5% of adult U.S. population (2); 8% of primary care patients
Etiology and Pathophysiology
- Idiopathic; appears to be a primary disorder of central pain processing (central sensitization) with afferent augmentation of peripheral nociceptive stimuli
- Alterations in neuroendocrine, neuromodulation, neurotransmitter, neurotransporter, biochemical, and neuroreceptor function/physiology
- Sleep abnormalities—α-wave intrusion
- Inflammation is not a feature of fibromyalgia.
- High familial aggregation
- Inheritance is unknown but likely polygenic.
- Odds ratio may be as high as 8.5 for a first-degree relative of a familial proband.
- Environmental—several triggers have been described:
- Physical trauma or severe illness
- Stressors (e.g., work, family, life events, and physical or sexual abuse)
- Viral and bacterial infections
- Female gender
- Poor functional status
- Negative/stressful life events
- Low socioeconomic status
No known strategies for prevention
Commonly Associated Conditions
- Often a comorbid condition with other rheumatologic or neurologic disorders
- Obesity is common and associated with increased severity of symptoms.